Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity

Journal of Neuroscience

Volumn 20, Issue 22, 2000, Pages 8443-8451

  Calabresi, P ^a   Gubellini, P ^a   Centonze, D ^a   Picconi, B ^a   Bernardi, G ^a   Chergui, K ^a   Svenningsson, P ^a   Fienberg, A A ^a   Greengard, P ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Basal ganglia; Brain slices; Dopamine; Intracellular recordings; Nitric oxide synthase positive interneurons; Phosphatases; Protein kinase C; Protein kinase G

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DOPAMINE; PHOSPHOPROTEIN DARPP 32;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRIATE CORTEX;

EID: 0034668949     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-22-08443.2000     Document Type: Article

References (41)

1. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP
2. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
3. Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis
4. Long-term synaptic depression in the striatum: Physiological and pharmacological characterization
5. Long-term potentiation in the striatum is unmasked by removing the voltage-dependent block of NMDA receptor channels
6. The corticostriatal projection: From synaptic plasticity to dysfunction of the basal ganglia
7. The neostriatum beyond the motor function: Experimental and clinical evidence
8. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors
9. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression
10. Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP
11. Acetylcholine-mediated modulation of striatal function
12. Characterization of phosphorylation sites on the glutamate receptor 4 subunit of the AMPA receptors
13. Unilateral dopamine denervation blocks corticostriatal LTP
14. In vivo activity-dependent plasticity at cortico-striatal connections: Evidence for physiological long-term potentiation
15. In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex
16. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses
17. Modulation of long-term synaptic plasticity at excitatory striatal synapses
18. DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission
19. The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia
20. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons
21. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
22. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor I
23. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1
24. Membrane properties and synaptic responses of rat striatal neurones in vitro
25. Striatal interneurones: Chemical, physiological and morphological characterization
26. Phenotypical characterization of the rat striatal neurons expressing D1 dopamine receptor gene
27. Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: Evidence for a dopaminergic regulation of striatal nitric oxide release
28. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones
29. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
30. NMDA receptors amplify calcium into dendritic spines during associative pre- and post-synaptic activation
31. Molecular biology of dopamine receptors
32. Phosphorylation of DARPP-32 and inhibitor-1 in rat choroids plexus: Regulation by factors other than dopamine
33. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (M(r) 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor
34. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo
35. Modulation of calcium currents by D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
36. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons
37. Characterization of the protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies
38. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
39. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cGMP-regulated phosphoprotein, in the substantia nigra
40. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro
41. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin